Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amylin
Amylin
A Possible Bidding War For Human Genome Sciences, But Celgene Is The Real Gem
Seeking Alpha
Mon, 07/9/12 - 10:12 am
M&A
Human Genome Sciences
Celgene
Amylin
GSK
Novo Nordisk
Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
Yahoo/BusinessWire
Sat, 07/7/12 - 11:29 am
Amylin
lawsuits
Amylin Deal Signals Diabetes Space is Hot
Motley Fool
Fri, 07/6/12 - 07:34 pm
diabetes
Amylin
M&A
Bristol-Myers Squibb
AstraZeneca
These 2 Big Pharma Stocks Will Leap By 2013 (BMY, PFE)
Seeking Alpha
Fri, 07/6/12 - 10:44 am
Abbott Laboratories
Amylin
Bristol-Myers Squibb
Novartis
Pfizer
Expert On The Amylin Purchase: 'I Hate This Deal'
Forbes
Tue, 07/3/12 - 01:07 pm
Amylin
Bristol-Myers Squibb
M&A
AstraZeneca
Today's Bio Pharma Buyout News And Watch List
Seeking Alpha
Tue, 07/3/12 - 11:38 am
Amylin
AstraZeneca
Obagi Medical Products
Eli Lilly
GSK
Bristol-Myers Squibb
Bristol-Myers acquisition a good strategic fit, says Deutsche Bank
Yahoo/Fly on the Wall
Mon, 07/2/12 - 10:41 am
Amylin
M&A
Bristol-Myers Squibb
Bristol-Myers Squibb and AstraZeneca Expand Diabetes Alliance Through Bristol-Myers Squibb’s Acquisition of Amylin Pharmaceuticals
Yahoo/BusinessWire
Sat, 06/30/12 - 03:28 pm
Bristol-Myers Squibb
AstraZeneca
Amylin
M&A
diabetes
Bristol-Myers To Acquire Diabetes Maker Amylin For $5.3 Billion
Bloomberg
Fri, 06/29/12 - 10:21 pm
Amylin
Bristol-Myers Squibb
M&A
diabetes
Novartis, four others weigh Amylin final bids: sources
Reuters
Tue, 06/26/12 - 01:26 pm
Novartis
Amylin
M&A
Bristol-Myers Squibb
AstraZeneca
Merck
Sanofi
FDA: Amylin Pharma Concealed Heart Safety Risks of Key Diabetes Drug
TheStreet.com
Mon, 06/25/12 - 03:29 pm
FDA
Amylin
Byetta
diabetes
Hostile Takeovers And The Race To Reduce Residual Risk In Heart Disease Patients
Seeking Alpha
Wed, 06/20/12 - 12:38 pm
M&A
heart disease
Human Genome Sciences
Amylin
GSK
Eli Lilly
Merck
Novo Nordisk
Pfizer
7 Healthcare Stocks Near Highs Being Bought Up By Hedge Funds
Seeking Alpha
Sat, 06/16/12 - 12:46 pm
Ardea Biosciences
Synta Pharmaceuticals
Akorn
Omeros
Santarus
Amylin
Ariad Pharmaceuticals
Sanofi, Novo Nordisk, Amylin all tout diabetes treatments at ADA
Fierce Pharma
Mon, 06/11/12 - 01:17 pm
Sanofi
Novo Nordisk
ADA
diabetes
Amylin
degludec
Lantus
Victoza
Monday's Bio Pharma Momentum Movers And Buy-Out Speculation List
Seeking Alpha
Mon, 06/11/12 - 11:26 am
Alkermes
Amylin
Arena Pharmaceuticals
GSK
Human Genome Sciences
Obagi Medical Products
Novo's Victoza Leads To Greater Weight Loss Than Byetta
Bloomberg
Mon, 06/11/12 - 10:47 am
Byetta
diabetes
Victoza
Novo Nordisk
Amylin
Symlin Use Helped Patients with Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range
Yahoo/Business Wire
Sat, 06/9/12 - 12:38 pm
Symlin
type 2 diabetes
diabetes
type 1 diabetes
Amylin
Once-Weekly Bydureon Provided Greater Glucose Control, Weight Loss and Lower Risk of Hypoglycemia Compared to Once- or Twice-Daily Levemir® in Type 2 Diabetes
Yahoo/Business Wire
Sat, 06/9/12 - 12:35 pm
type 2 diabetes
diabetes
Bydureon
Amylin
Alkermes
Bydureon Improved A1C, Fasting Glucose, Pulse Pressure and Weight Regardless of Baseline Body Weight in Patients with Type 2 Diabetes
Yahoo/Business Wire
Sat, 06/9/12 - 12:33 pm
Bydureon
type 2 diabetes
Amylin
Alkermes
diabetes
Byetta Provided Greater Glycemic Durability and Overall Glycemic Control than Amaryl® in Patients with Type 2 Diabetes
Yahoo/Business Wire
Sat, 06/9/12 - 12:31 pm
Byetta
Amylin
diabetes
type 2 diabetes
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »